Consensus principles from radiation biology were used to describe a generic set of nonlinear, first-order differential equations for modeling toxicity-induced compensatory 
Introduction
An editorial in The American Statistician by A.S.C. Ehrenberg (1) , derived from experiences with business and marketing, insightfully describes a belief that analysis of many sets of data (MSOD) "seems to be the only way in which we can produce results that are generalizable, lawlike, and predictable-which in fact hold for many sets of data ... our concern will be with deciding what the main effect is quantitatively, how to model it, how consistent it is, under what different conditions it does or does not occur, why it arises, how it links up with other findings, and how it can be used in practical applications and/or in the development of theory."
Although we have used such practices for nearly 20 years-in carcinogenic risk assessments, mathematical models of acute lethality, and marrow cell kinetics underlying radiation-induced hematopoiesis-we did not attempt to communicate those generalized ideas outside our particular areas of interest, nor have we stated the essential ideas so compactly.
For mathematical models of doseresponse effects, historically there has been a near-total reliance upon finding a simple equation that will approximate a single set of experimental data (SSOD) when the numerical constants are fitted appropriately. Fits to other data sets, from similar experimental protocols, require additional statistical justification that the model is acceptable and require new fitted parameters. Although continued use of the same functional form usually produces some attempt to establish a biological interpretation of the underlying effects (i.e., a conceptual model), in general, such interpretations usually have no fundamental validity and ignore far more important biological factors than the few they are hypothesized to approximate; even for those few factors, there is a pronounced lack of generality for protracted-, fractionated-, or variable-rate exposure protocols. Results from such exercises are without substantial validity outside the ranges of experimental conditions used and have no basis in reality when extrapolated in terms of dose, dose rate, or test species/strain used.
The general domain of biologically based or conceptual models bifurcates into additional basic approaches. One pathway involves assumptions, either direct or indirect, that the important processes are known in terms of specific molecular/cellular effects, and simple factors and descriptive models can be written accordingly. When indirect assumptions are involved, it is often overlooked that the conclusions obtained from experiment-by-experiment evaluations of the models are mandated either by the constraints of the model or by limitations of the particular experiment used to estimate parameters. Subtle, indirect assumptions have the hazard of going unrecognized, perhaps even to the researchers themselves.
Our approach formulates generalized dose-response models in terms of generic processes: molecular effects, from a cell kinetics perspective, and descriptions of local and systemic reactions that may act through cell-to-cell and/or humoral-mediated effects involving hormones, chalones, or cytokines. The dosing schedules used for benzene experiments do not reflect adequate protocol-dependent variability to permit use of the MSOD approach to a degree that would provide insight into underlying biological mechanisms. In contrast, historical data from radiation biology do reflect those needed variations in experimental design. Those variations can be found at the molecular, cellular, organ, and organism levels, and all of those structural tiers have been considered to various degrees in model conceptualization, coefficient estimation, and model validation in our previous publications on radiation-induced hematopoiesis (2, 3) . Because our maximum likelihood estimations (MLE) have relied only upon lethality data from both short-term and long-term irradiations, those experiments, as summarized in Figure 1 , serve as the database to evaluate the generic model in terms of cells critical to hematopoietic recovery (4, 5) .
Following is a brief description of how we have formulated a generic model for cell kinetics associated with radiationinduced hematopoiesis and how MSODs can be used to generalize the model and provide insight into the fundamental underlying mechanisms. As indicated in Table 1 , the conceptual and mathematical models used for ionizing radiations, should also be relevant to considerations of benzene toxicity. Experimental data needed to estimate model parameters are fragmentary. Specifically, our intent was to use dogmatic terms and factors (or, as a minimum condition of acceptance those common to expert consensus) to approximate generic processes associated with marrow cell kinetics underlying acute lethality. Next, MLE methods were used to evaluate the numerical parameters of the models and their associated confidence bounds. This approach provides no direct cause-effect proof that the biologically based model is indeed correct in all details, but, because enormous sets of data, reflecting wide ranges of variability, can be fitted by a common set of evaluated parameters that are consistent with specific biological rate constants, it is obvious that the model is substantially correct in behavior and provides hypotheses that in turn may be validated or modified by further refinement of experimental design. In addition, we found it desirable to evaluate and test a cell kinetics model formulated in terms of those same nonspecific damage, repair, and repopulation processes as derived from colony-forming unit-spleen (CFU-S) experiments, in contrast to the parallel evaluation made from the generic model and animal lethality data (i.e., the underlying dependence on critical cells is not restricted to stem or CFU-S types of cells). [1] nIN=-XIKDn'I-XINFINnI + XNIDfnN [2] nK = XNKD nN+ XIKDfnI. [3] In these equations, X is the rate constant that mediates movement of cells from normal or injured states as indicated by the first subscript to the state indicated by the second subscript. D is dose given uniformly to marrow, and prime denotes the derivative of a cell count or dose (i.e., dose rate) with respect to time. Factors and terms of Equations 1 to 3 are given in Tables 2 and 3 .
Materials and Methods
The same functional form based on cellular damage, repair, and repopulation was evaluated from experimental studies on CFU-S cells as described in a previous reference (3) . Damage constants were estimated from dose-rate data of Puro and Clark (6) . The proliferation constant was estimated n -ti-letely in terms of biologically related half-life, activate different mechanisms, or :pts involving populations of cells, are associated with toxicity to nonhemaof the mitotic cycles, mitotic delay topoietic organs may not necessarily act in , etc. Thus, although the injury used the manner shown. nulate the recovery shown in Figure 3 Benzene is highly mobile inside the ue to ionizing radiations, other insults body and for simplicity may, like ionizing 5S chemical and/or surgical ablation of radiations, be expected to act primarily arrow used to create similar injury upon cells present in the body at the time in principle, be compensated for of exposure. For example, Rickert et al. (8) ling to recovery aspects of Figure 4 . found the benzene half-times in different urse, insults that have a long biological organs of male Fischer-344 rats to be 48 min over the first 9 hr of exposure to 500 ppm by inhalation. Table 5 .
ted for compensatory repopulation as described e 2 and the text. The vectors are used to indi-repopulation by a particular cell is modeled inges as estimated from the experimental data by ANNMFNN. The doubling time, TD, led in Table 4 . associated with a particular surviving Several publications have concluded that injury to both hematopoietic stem cells and their cellular/cytokine-mediated environment can be important to acute mortality and leukemogenesis. A number of experimental studies have found that all marrowderived lineages can be regenerated from only one cell alone surviving pluripotent stem cell, whereas a stroma of strong functional integrity is required to support that regeneration. The importance of stem and stromal lineages, especially as potentially related to benzene toxicity, has been discussed previously (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . In 1961, Cronkite (26) concluded that any agent which produces marrow aplasia is a "putative leukemogen." Later, Adamson and Seiber (27) j.
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jp: P. . . .iu-'S.. Cronkite et al. (29) Doubling time: Seems to be about 2 days from a survival of 1 0% and 4 days from a survival of 20%; times close to the previous study of Cronkite et al. (27) .
Environmental Health Perspectives -Vol 104, Supplement 6 * December 1996 have been exposed to leukemogenic initiating agents before benzene exposure) to undergo compensatory hematopoiesis. Because of existing data and simple, well-established dosimetry models, the quantitative considerations, as described here, have been limited to exposures involving ionizing radiations, and the relevance to benzene toxicity is implied by analogy of molecular-, cellular-, and organ-based processes. As illustrated in Figure 5 , our generic model of radiation-induced compensatory hematopoiesis has led to a strongly supported hypothesis that cell-to-cell contact and/or cytokine-mediated processes between stomal and stem cells establish both the radiosensitivity and proliferation kinetics of the cells that are critical to hematopoietic recovery (28, 29) . Although that hypothesis is well supported by a large array of stromal cell experiments, it is still contested by some, based on the belief that survival of hematopoietic stem cells is both necessary and sufficient for rescue from hematopoietic syndrome. In contrast, the model evaluations described in this paper indicate that even though stem cell survival is necessary, the rate-limiting considerations seem to be associated with a more radioresistant and more slowly repopulating critical cell that is consistent with characteristics measured for marrow stroma and CFU-F type lineages. . Scheme based on consenus principles from radiation biology and from the results of our many model evaluations and validations. Clearly, the supporting stromal tissues and their cytokine-mediated control of compensatory hematopoiesis are obligatory to recovery from toxic injury.
